Barron's Archives - PharmaLive

Biotech Stocks Take Hit as Wary Investors Look Elsewhere

Barron's, Biotech, Business, Coronavirus Disease (COVID-19) Pandemic, FDA/Regulatory, Financial Times, Financials, Investors, Nasdaq Biotech Index, Stocks

Over the past six months, the Nasdaq Biotechnology Index has declined more than 20%. Some of the falling prices appear to be due to some investors losing interest in many companies that soared into favor during the COVID-19 pandemic. And these companies that have seen declining investor interest are now struggling to raise finances, according to BioSpace

February 10, 2022/by BioSpace

Agilent Technologies is Most Sustainable Health Care Company, Survey Shows

Amgen, Barron's, Coronavirus Disease (COVID-19) Pandemic, Diagnostics, Merck, Sustainability

For the second year in a row, California-based Agilent Technologies – a leader in diagnostics and applied chemical markets – was ranked as one of Barron’s most sustainable companies.

February 19, 2021/by Andrew Humphreys